Just about any kind of charged particle will give you a Bragg peak - the heavier the particle, the sharper the peak tends to be. Even electrons tracks technically have a Bragg peak, it's just that they scatter so much it can't really be taken advantage of the way it is with protons and heavier ions.
Over the years a number of heavier ions have been explored: carbon, neon, silicon, argon, etc. I think there are a few carbon ion facilities up and running at the moment. While there may be an advantage in the basic physics in terms of beam delivery (i.e. using the spread-out Bragg peak to target a specific volume and taking advantage of the higher linear energy transfer properties of such beams), I think there are still questions in terms of clinical outcome and whether any small gains due to the technology outweigh the enormous increase in cost. On top of that we also still struggle with the issue of identifying the precise location of the cancer in the first place (and the fact that it can move around), which means that the even though we may be able to deliver much more conformal doses in principle, we don't necessarily see that translate into major differences in clinical outcomes.